<VariationArchive VariationID="1802145" VariationName="NM_213599.3(ANO5):c.[1520del];[155A&gt;G]" VariationType="CompoundHeterozygote" Accession="VCV001802145" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2023-02-07" MostRecentSubmission="2022-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="1802145">
      <SimpleAllele AlleleID="191740" VariationID="194577">
        <GeneList>
          <Gene Symbol="ANO5" FullName="anoctamin 5" GeneID="203859" HGNC_ID="HGNC:27337" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>11p14.3</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22192473" stop="22283357" display_start="22192473" display_stop="22283357" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22214721" stop="22304912" display_start="22214721" display_stop="22304912" Strand="+" />
            </Location>
            <OMIM>608662</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_213599.3(ANO5):c.1520del (p.Phe507fs)</Name>
        <CanonicalSPDI>NC_000011.10:22259629:TT:T</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>11p14.3</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22259630" stop="22259630" display_start="22259630" display_stop="22259630" variantLength="1" positionVCF="22259629" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22281176" stop="22281176" display_start="22281176" display_stop="22281176" variantLength="1" positionVCF="22281175" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        </Location>
        <ProteinChange>F506fs</ProteinChange>
        <ProteinChange>F507fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.22259631del" Assembly="GRCh38">
              <Expression>NC_000011.10:g.22259631del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.22281177del" Assembly="GRCh37">
              <Expression>NC_000011.9:g.22281177del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_015844.1" sequenceAccession="NG_015844" sequenceVersion="1" change="g.71456del">
              <Expression>NG_015844.1:g.71456del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001142649.2" sequenceAccession="NM_001142649" sequenceVersion="2" change="c.1517del">
              <Expression>NM_001142649.2:c.1517del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001136121.1" sequenceAccession="NP_001136121" sequenceVersion="1" change="p.Phe506fs">
              <Expression>NP_001136121.1:p.Phe506fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.1520del" MANESelect="true">
              <Expression>NM_213599.3:c.1520del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_998764.1" sequenceAccession="NP_998764" sequenceVersion="1" change="p.Phe507fs">
              <Expression>NP_998764.1:p.Phe507fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_868" sequenceAccession="LRG_868">
              <Expression>LRG_868:g.71456del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_213599.2" sequenceAccession="NM_213599" sequenceVersion="2" change="c.1520delT">
              <Expression>NM_213599.2:c.1520delT</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_868t1" sequenceAccession="LRG_868t1">
              <Expression>LRG_868t1:c.1520del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.1520delT" MANESelect="true">
              <Expression>NM_213599.3:c.1520delT</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-11-10" DateCreated="2015-06-25" MostRecentSubmission="2024-07-10" NumberOfSubmissions="8" NumberOfSubmitters="8">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">21186264</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">22402862</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">22980763</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23041008</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23606453</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25891276</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">30919934</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ANO5</URL>
            </Citation>
            <ConditionList>
              <TraitSet ID="12373" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="9521" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy</ElementValue>
                    <XRef ID="MONDO:0015152" DB="MONDO" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="19825" />
                    <XRef ID="19825" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <XRef ID="102015" DB="Orphanet" />
                  <XRef ID="C2931907" DB="MedGen" />
                  <XRef ID="MONDO:0015152" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS253600" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="39863" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="1391" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                    <XRef Type="MIM" ID="166260" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                    <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                    <XRef ID="MONDO:0008151" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">GDD</ElementValue>
                    <XRef Type="MIM" ID="166260" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="8698" />
                    <XRef ID="8698" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <XRef ID="53697" DB="Orphanet" />
                  <XRef ID="C1833736" DB="MedGen" />
                  <XRef ID="MONDO:0008151" DB="MONDO" />
                  <XRef Type="MIM" ID="166260" DB="OMIM" />
                </Trait>
                <Trait ID="2991" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                    <XRef Type="MIM" ID="611307" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                    <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                    <XRef ID="MONDO:0012652" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR12</ElementValue>
                    <XRef Type="MIM" ID="611307" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="12536" />
                    <XRef ID="12536" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                    <XRef ID="NBK114459" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">23193613</ID>
                    <ID Source="BookShelf">NBK114459</ID>
                  </Citation>
                  <XRef ID="206549" DB="Orphanet" />
                  <XRef ID="C1969785" DB="MedGen" />
                  <XRef ID="MONDO:0012652" DB="MONDO" />
                  <XRef Type="MIM" ID="611307" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="553" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2991" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                    <XRef Type="MIM" ID="611307" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                    <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                    <XRef ID="MONDO:0012652" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR12</ElementValue>
                    <XRef Type="MIM" ID="611307" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="12536" />
                    <XRef ID="12536" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                    <XRef ID="NBK114459" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">23193613</ID>
                    <ID Source="BookShelf">NBK114459</ID>
                  </Citation>
                  <XRef ID="206549" DB="Orphanet" />
                  <XRef ID="C1969785" DB="MedGen" />
                  <XRef ID="MONDO:0012652" DB="MONDO" />
                  <XRef Type="MIM" ID="611307" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA201242" DB="ClinGen" />
          <XRef Type="rs" ID="794727158" DB="dbSNP" />
          <XRef Type="Interpreted" ID="1802145" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="194564" VariationID="197403">
        <GeneList>
          <Gene Symbol="ANO5" FullName="anoctamin 5" GeneID="203859" HGNC_ID="HGNC:27337" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>11p14.3</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22192473" stop="22283357" display_start="22192473" display_stop="22283357" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22214721" stop="22304912" display_start="22214721" display_stop="22304912" Strand="+" />
            </Location>
            <OMIM>608662</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_213599.3(ANO5):c.155A&gt;G (p.Asn52Ser)</Name>
        <CanonicalSPDI>NC_000011.10:22218261:A:G</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>11p14.3</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22218262" stop="22218262" display_start="22218262" display_stop="22218262" variantLength="1" positionVCF="22218262" referenceAlleleVCF="A" alternateAlleleVCF="G" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22239808" stop="22239808" display_start="22239808" display_stop="22239808" variantLength="1" positionVCF="22239808" referenceAlleleVCF="A" alternateAlleleVCF="G" />
        </Location>
        <ProteinChange>N52S</ProteinChange>
        <ProteinChange>N51S</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.22239808A&gt;G" Assembly="GRCh37">
              <Expression>NC_000011.9:g.22239808A&gt;G</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.22218262A&gt;G" Assembly="GRCh38">
              <Expression>NC_000011.10:g.22218262A&gt;G</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_015844.1" sequenceAccession="NG_015844" sequenceVersion="1" change="g.30087A&gt;G">
              <Expression>NG_015844.1:g.30087A&gt;G</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001142649.2" sequenceAccession="NM_001142649" sequenceVersion="2" change="c.152A&gt;G">
              <Expression>NM_001142649.2:c.152A&gt;G</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001136121.1" sequenceAccession="NP_001136121" sequenceVersion="1" change="p.Asn51Ser">
              <Expression>NP_001136121.1:p.Asn51Ser</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.155A&gt;G" MANESelect="true">
              <Expression>NM_213599.3:c.155A&gt;G</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_998764.1" sequenceAccession="NP_998764" sequenceVersion="1" change="p.Asn52Ser">
              <Expression>NP_998764.1:p.Asn52Ser</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_868" sequenceAccession="LRG_868">
              <Expression>LRG_868:g.30087A&gt;G</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_868t1" sequenceAccession="LRG_868t1">
              <Expression>LRG_868t1:c.155A&gt;G</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_868p1" sequenceAccession="LRG_868p1" change="p.Asn52Ser">
              <Expression>LRG_868p1:p.Asn52Ser</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-05-01" DateCreated="2015-06-25" MostRecentSubmission="2024-07-10" NumberOfSubmissions="11" NumberOfSubmitters="11">
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description>Conflicting classifications of pathogenicity</Description>
            <Explanation DataSource="ClinVar" Type="public">Uncertain significance(6); Benign(1); Likely benign(3)</Explanation>
            <Citation Type="general">
              <ID Source="PubMed">22980763</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23041008</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23606453</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25326637</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25891276</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">26810512</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">26911675</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">30564623</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">30919934</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">31517061</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">31931849</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">32419263</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">35563815</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">36157496</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ANO5</URL>
            </Citation>
            <Comment DataSource="ClinVar" Type="public">Uncertain significance(6); Benign(1); Likely benign(3)</Comment>
            <DescriptionHistory Dated="2017-12-15">
              <Description>Likely benign</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2016-12-05">
              <Description>Uncertain significance</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="39863" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="1391" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                    <XRef Type="MIM" ID="166260" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                    <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                    <XRef ID="MONDO:0008151" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">GDD</ElementValue>
                    <XRef Type="MIM" ID="166260" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="8698" />
                    <XRef ID="8698" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <XRef ID="53697" DB="Orphanet" />
                  <XRef ID="C1833736" DB="MedGen" />
                  <XRef ID="MONDO:0008151" DB="MONDO" />
                  <XRef Type="MIM" ID="166260" DB="OMIM" />
                </Trait>
                <Trait ID="2991" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                    <XRef ID="MONDO:0012652" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                    <XRef Type="MIM" ID="611307" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                    <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR12</ElementValue>
                    <XRef Type="MIM" ID="611307" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="12536" />
                    <XRef ID="12536" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                    <XRef ID="NBK114459" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">23193613</ID>
                    <ID Source="BookShelf">NBK114459</ID>
                  </Citation>
                  <XRef ID="206549" DB="Orphanet" />
                  <XRef ID="C1969785" DB="MedGen" />
                  <XRef ID="MONDO:0012652" DB="MONDO" />
                  <XRef Type="MIM" ID="611307" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="552" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="1391" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                    <XRef Type="MIM" ID="166260" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                    <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                    <XRef ID="MONDO:0008151" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">GDD</ElementValue>
                    <XRef Type="MIM" ID="166260" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="8698" />
                    <XRef ID="8698" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <XRef ID="53697" DB="Orphanet" />
                  <XRef ID="C1833736" DB="MedGen" />
                  <XRef ID="MONDO:0008151" DB="MONDO" />
                  <XRef Type="MIM" ID="166260" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="12088" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="18348" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">ANO5-Related Muscle Diseases</ElementValue>
                  </Name>
                  <XRef ID="CN180644" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="16789" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not specified</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
                  </AttributeSet>
                  <XRef ID="CN169374" DB="MedGen" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA245507" DB="ClinGen" />
          <XRef Type="rs" ID="143777403" DB="dbSNP" />
          <XRef Type="Interpreted" ID="424764" DB="ClinVar" />
          <XRef Type="Interpreted" ID="1802145" DB="ClinVar" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00109" Source="1000 Genomes Project 30x" />
          <AlleleFrequency Value="0.00120" Source="1000 Genomes Project" />
          <AlleleFrequency Value="0.00190" Source="Exome Aggregation Consortium (ExAC)" />
          <AlleleFrequency Value="0.00215" Source="The Genome Aggregation Database (gnomAD), exomes" />
          <AlleleFrequency Value="0.00229" Source="Trans-Omics for Precision Medicine (TOPMed)" />
          <AlleleFrequency Value="0.00238" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00254" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        </AlleleFrequencyList>
        <GlobalMinorAlleleFrequency Value="0.00120" Source="1000 Genomes Project" MinorAllele="G" />
      </SimpleAllele>
      <Name>NM_213599.3(ANO5):c.[1520del];[155A&gt;G]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression MANESelect="true">
            <Expression>NM_213599.3:c.[1520del];[155A&gt;G]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_213599.3(ANO5):c.[1520del];[155A&gt;G] AND multiple conditions" Accession="RCV002464963" Version="6">
        <ClassifiedConditionList TraitSetID="9870">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2750076">Miyoshi muscular dystrophy 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-07" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-07" MostRecentSubmission="2022-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9870" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
            <Trait ID="6803" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Miyoshi myopathy 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 3</ElementValue>
                <XRef ID="Miyoshi+muscular+dystrophy+3/8905" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013222" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD3</ElementValue>
                <XRef Type="MIM" ID="613319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17653" />
                <XRef ID="17653" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="399096" DB="Orphanet" />
              <XRef ID="C2750076" DB="MedGen" />
              <XRef ID="MONDO:0013222" DB="MONDO" />
              <XRef Type="MIM" ID="613319" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5398391" SubmissionDate="2022-12-07" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="variant:3236558" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002759325" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital TÃ¼bingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0003198" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0003236" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0040185" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0009130" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="ANO5" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <Location>
              <SequenceLocation Assembly="GRCh38" Chr="11" alternateAllele="G" referenceAllele="A" start="22218262" stop="22218262" />
            </Location>
            <OtherNameList>
              <Name Type="SubmitterVariantId">148739</Name>
            </OtherNameList>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="ANO5" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <Location>
              <SequenceLocation Assembly="GRCh38" Chr="11" alternateAllele="C" referenceAllele="CT" start="22259629" stop="22259630" />
            </Location>
            <OtherNameList>
              <Name Type="SubmitterVariantId">148739</Name>
            </OtherNameList>
          </SimpleAllele>
          <OtherNameList>
            <Name Type="SubmitterVariantId">148739</Name>
          </OtherNameList>
          <VariationType>CompoundHeterozygote</VariationType>
          <AttributeSet>
            <Attribute Type="HGVS">g[22218262A&gt;G];[22259630del]</Attribute>
          </AttributeSet>
        </Genotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="206549" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="399096" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="53697" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12378934</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003236" MappingRef="HP">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="HP:0040185" MappingRef="HP">
        <MedGen CUI="C2751260" Name="Macrothrombocytopenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="53697" MappingRef="Orphanet">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="HP:0009130" MappingRef="HP">
        <MedGen CUI="C0239830" Name="Hand muscle atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003198" MappingRef="HP">
        <MedGen CUI="C0026848" Name="Myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="399096" MappingRef="Orphanet">
        <MedGen CUI="C2750076" Name="Miyoshi muscular dystrophy 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5398391" TraitType="Disease" MappingType="XRef" MappingValue="206549" MappingRef="Orphanet">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

